| Detected | Trial | Change |
|---|---|---|
| 2026-05-20 | NCT07551544 ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed… |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-05-20 | NCT07551544 ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed… |
Enrollment reduced: 688 -> 0 participants |
| 2026-05-15 | NCT06810141 ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle… |
Trial sites expanded: 62 -> 66 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-04 | NCT07628062 Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06745908 | Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and… | NSCLC Stage IV | Recruiting |
| NCT07524257 | Phase 3 Study of Nogapendekin Alfa Inbakicept Plus Standard of Care vs Standard of Care… | NSCLC (Advanced Non-small Cell Lung Cancer) | Not Yet Recruiting |
| Phase 2 | |||
| NCT06061809 | N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma | Glioblastoma | Recruiting |
| NCT07125872 | Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma | Relapsed B-Cell Non Hodgkin Lymphoma | Recruiting |
| NCT07108036 | A Study to Assess Anktiva in Patients With Long Covid-19. | Long COVID | Recruiting |
| NCT07123727 | A Study to Examine Anktiva for the Treatment of COVID-19. | Long COVID | Recruiting |
| NCT03228667 | QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT07477366 | Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin… | Relapsed B-Cell Non-Hodgkin Lymphoma | Not Yet Recruiting |
| NCT07578558 | NAI for Sepsis With Persistent Lymphopenia | Sepsis | Not Yet Recruiting |
| NCT07628062 | Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal… | HPV-Positive Oropharyngeal Squamous Cell Carcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06800963 | ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC… | NMIBC | Recruiting |
| NCT02138734 | A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle… | Non-muscle Invasive Bladder Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT05618925 | Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma | Non Hodgkin's Lymphoma Refractory/Relapsed | Recruiting |
| NCT07556757 | A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic… | B-ALL | Recruiting |
| NCT06334991 | Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma | Non-Hodgkin Lymphoma Refractory/ Relapsed | Recruiting |
| NCT07488884 | Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept… | Pancreatic Cancer Resectable | Not Yet Recruiting |
| Not specified | |||
| NCT05981131 | Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer… | Non Muscle Invasive Bladder Cancer | Active, Not Recruiting |